Physician profile
Mimi Lin
NPI 1659588457
$61,250.93
in general payments reported to CMS, 2019-2025
30 companies · $3,943 in 2025
The $3,943 reported for 2025 was more than what 89% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $8,253 · 2021: $11K · 2022: $19K · 2023: $376 · 2024: $3,569 · 2025: $3,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,491 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,475 · Food and Beverage: $1,820 · Travel and Lodging: $82.30 · Education: $19.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,491.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,475.00 |
| Food and Beverage | $1,819.98 |
| Travel and Lodging | $82.30 |
| Education | $19.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17,866.05 | 2019-2020 | |
| Evoke Pharma, INC. | $16,606.18 | 2022 | |
| Abbvie INC. | $9,709.06 | 2019-2025 | |
| Nestle Healthcare Nutrition INC. | $6,000.00 | 2020-2021 | |
| Olympus Medical Systems Corporation | $3,491.00 | 2025 | Evis Exera II Small Intestinal Videoscope |
| Medtronic, INC. | $3,009.47 | 2024 | Endoflip, Interstim, Gi Genius |
| Ardelyx, INC. | $1,500.00 | 2022 | |
| Olympus Corporation | $1,050.00 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $264.08 | 2019-2025 | Entyvio |
| Enterra Medical, INC. | $228.37 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $201.89 | 2019 | |
| Ironwood Pharmaceuticals, INC | $199.17 | 2019 | |
| Janssen Biotech, INC. | $156.83 | 2019-2024 | Stelara, Tremfya, Simponi |
| Intuitive Surgical, INC. | $129.74 | 2025 | |
| Qol Medical, LLC | $122.43 | 2022-2024 | Sucraid, Sucraid |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $118.42 | 2019-2024 | |
| Celltrion USA INC. | $108.59 | 2024-2025 | Vegzelma, Zymfentra |
| Genzyme Corporation | $72.67 | 2023 | |
| Lilly USA, LLC | $64.75 | 2024-2025 | Omvoh |
| Braintree Laboratories, INC. | $63.12 | 2019-2025 | Suflave, Sutab |
| Ferring Pharmaceuticals INC. | $56.29 | 2019-2020 | |
| Gilead Sciences, INC. | $48.71 | 2020-2024 | |
| Myriad Genetic Laboratories, INC. | $42.75 | 2023 | Precisetumor |
| Olympus America INC. | $39.98 | 2024 | Endoclot Phs |
| Shire North American Group INC | $21.16 | 2019 | |
| Intercept Pharmaceuticals, INC. | $18.83 | 2019 | |
| Novo Nordisk INC | $17.60 | 2025 | Wegovy |
| Hologic INC | $16.51 | 2020 | |
| Medtronic USA, INC. | $14.43 | 2019 | |
| Celgene Corporation | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mimi Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.